These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34970991)

  • 1. Association of daily sleep duration with the incident dementia by serum soluble TREM2 in a community.
    Ohara T; Hata J; Tanaka M; Honda T; Yamakage H; Inoue T; Hirakawa Y; Kusakabe T; Shibata M; Kitazono T; Nakao T; Satoh-Asahara N; Ninomiya T
    J Am Geriatr Soc; 2022 Apr; 70(4):1147-1156. PubMed ID: 34970991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study.
    Ohara T; Hata J; Tanaka M; Honda T; Yamakage H; Yoshida D; Inoue T; Hirakawa Y; Kusakabe T; Shibata M; Teraoka T; Kitazono T; Kanba S; Satoh-Asahara N; Ninomiya T
    Ann Neurol; 2019 Jan; 85(1):47-58. PubMed ID: 30485483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Daily Sleep Duration and Risk of Dementia and Mortality in a Japanese Community.
    Ohara T; Honda T; Hata J; Yoshida D; Mukai N; Hirakawa Y; Shibata M; Kishimoto H; Kitazono T; Kanba S; Ninomiya T
    J Am Geriatr Soc; 2018 Oct; 66(10):1911-1918. PubMed ID: 29873398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: The Hisayama study.
    Tanaka M; Honda T; Yamakage H; Hata J; Yoshida D; Hirakawa Y; Shibata M; Inoue T; Kusakabe T; Satoh-Asahara N; Ninomiya T
    Diabetes Res Clin Pract; 2018 Dec; 146():225-232. PubMed ID: 30339787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in sleep duration and the risk of incident dementia in the elderly Japanese: the Ohsaki Cohort 2006 Study.
    Lu Y; Sugawara Y; Zhang S; Tomata Y; Tsuji I
    Sleep; 2018 Oct; 41(10):. PubMed ID: 30053239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study.
    Hu HY; Ma LZ; Hu H; Bi YL; Ma YH; Shen XN; Ou YN; Dong Q; Tan L; Yu JT
    Neurotox Res; 2021 Aug; 39(4):1372-1380. PubMed ID: 34097185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1.
    Tanaka M; Yamakage H; Muranaka K; Yamada T; Araki R; Ogo A; Matoba Y; Watanabe T; Saito M; Kurita S; Yonezawa K; Tanaka T; Suzuki M; Sawamura M; Matsumoto M; Nishimura M; Kusakabe T; Wada H; Hasegawa K; Kotani K; Noda M; Satoh-Asahara N
    Front Endocrinol (Lausanne); 2022; 13():880148. PubMed ID: 35592778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of serum soluble TREM2 with vascular dementia in Chinese Han population.
    Wang Q; Xu Y; Qi C; Liu A; Zhao Y
    Int J Neurosci; 2020 Jul; 130(7):708-712. PubMed ID: 31847649
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between daily sleep duration and the risk of incident dementia according to the presence or absence of diseases among older Japanese individuals in the New Integrated Suburban Seniority Investigation (NISSIN) project.
    Ukawa S; Zhao W; Okabayashi S; Kimura T; Ando M; Wakai K; Tsushita K; Kawamura T; Tamakoshi A
    Sleep Med; 2022 Dec; 100():190-195. PubMed ID: 36113230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble TREM2 is associated with death and cardiovascular events after acute ischemic stroke: an observational study from CATIS.
    Lu Y; Zhao Y; Zhang Q; Fang C; Bao A; Dong W; Peng Y; Peng H; Ju Z; He J; Zhang Y; Xu T; Zhong C
    J Neuroinflammation; 2022 Apr; 19(1):88. PubMed ID: 35414082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
    Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
    Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis Patients.
    Cuciuc V; Tshori S; Grib L; Sella G; Tuvali O; Volodarsky I; Welt M; Fassler M; Shimoni S; George J
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease.
    Bekris LM; Khrestian M; Dyne E; Shao Y; Pillai JA; Rao SM; Bemiller SM; Lamb B; Fernandez HH; Leverenz JB
    J Neuroimmunol; 2018 Jun; 319():19-27. PubMed ID: 29685286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report.
    Weber GE; Koenig KA; Khrestian M; Shao Y; Tuason ED; Gramm M; Lal D; Leverenz JB; Bekris LM
    J Immunol; 2020 Mar; 204(5):1111-1118. PubMed ID: 31959733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
    Henjum K; Almdahl IS; Årskog V; Minthon L; Hansson O; Fladby T; Nilsson LN
    Alzheimers Res Ther; 2016 Apr; 8(1):17. PubMed ID: 27121148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
    Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
    Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 expression in the brain and biological fluids in prion diseases.
    Diaz-Lucena D; Kruse N; Thüne K; Schmitz M; Villar-Piqué A; da Cunha JEG; Hermann P; López-Pérez Ó; Andrés-Benito P; Ladogana A; Calero M; Vidal E; Riggert J; Pineau H; Sim V; Zetterberg H; Blennow K; Del Río JA; Marín-Moreno A; Espinosa JC; Torres JM; Sánchez-Valle R; Mollenhauer B; Ferrer I; Zerr I; Llorens F
    Acta Neuropathol; 2021 Jun; 141(6):841-859. PubMed ID: 33881612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson's Disease.
    Mo M; Tang Y; Wei L; Qiu J; Peng G; Lin Y; Zhou M; Dai W; Zhang Z; Chen X; Liu H; Ding L; Ye P; Wu Y; Zhu X; Wu Z; Guo W; Xu P
    Front Aging Neurosci; 2021; 13():753210. PubMed ID: 34658845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.